Cargando…
Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease
BACKGROUND: Diagnosis and treatment for venous thromboembolic disease (VTE) have evolved considerably through diagnostic and therapeutic innovations. Despite their considerable potential for enhancing care, however, the extent to which these innovations are being adopted in usual practice is unknown...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Medicine Publications, Inc
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085085/ https://www.ncbi.nlm.nih.gov/pubmed/25009684 |
_version_ | 1782324605928603648 |
---|---|
author | Southern, Danielle A Poole, Jasmine Patel, Alka Waters, Nigel Pilote, Louise Hull, Russell D Ghali, William A |
author_facet | Southern, Danielle A Poole, Jasmine Patel, Alka Waters, Nigel Pilote, Louise Hull, Russell D Ghali, William A |
author_sort | Southern, Danielle A |
collection | PubMed |
description | BACKGROUND: Diagnosis and treatment for venous thromboembolic disease (VTE) have evolved considerably through diagnostic and therapeutic innovations. Despite their considerable potential for enhancing care, however, the extent to which these innovations are being adopted in usual practice is unknown. We documented the infrastructure available in hospitals and health regions across Canada for provision of optimal diagnosis and therapy for VTE disease. METHODS: Over the period January 2008 through October 2009, we studied health system infrastructure for care of VTE disease in Canada's 10 provinces and 3 territories and all 94 health regions therein. We interviewed health system managers and/or clinical leaders from all 658 acute care hospitals in Canada and documented key elements of health system infrastructure at the hospital level for these institutions. RESULTS: There was considerable variation across Canada in the availability of key infrastructure for the diagnosis and management of VTE disease. Provinces with higher populations tended to have a large proportion of hospitals with capability to measure d-dimer levels, whereas less populated provinces were more likely to send samples to centralized analysis facilities for d-dimer testing. All provinces and territories had some facilities offering advanced diagnostic imaging, but the number of institutions and the availability of imaging were highly variable (with the proportion offering at least limited availability ranging from 0% to 90%). Only 6 provinces had regions with availability of dedicated early and/or long-term outpatient clinics for VTE disease. CONCLUSIONS: Infrastructure in Canada for optimal care of patients with VTE disease was suboptimal during the study period and was not entirely in step with the evidence. Such shortfalls in health system infrastructure limit the extent to which health care providers can deliver optimal, evidence-based care to their patients. Nationwide evaluations of health system infrastructure such as this one should be undertaken internationally to better characterize quality of care and potential for improvement. |
format | Online Article Text |
id | pubmed-4085085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Open Medicine Publications, Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-40850852014-07-09 Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease Southern, Danielle A Poole, Jasmine Patel, Alka Waters, Nigel Pilote, Louise Hull, Russell D Ghali, William A Open Med Research BACKGROUND: Diagnosis and treatment for venous thromboembolic disease (VTE) have evolved considerably through diagnostic and therapeutic innovations. Despite their considerable potential for enhancing care, however, the extent to which these innovations are being adopted in usual practice is unknown. We documented the infrastructure available in hospitals and health regions across Canada for provision of optimal diagnosis and therapy for VTE disease. METHODS: Over the period January 2008 through October 2009, we studied health system infrastructure for care of VTE disease in Canada's 10 provinces and 3 territories and all 94 health regions therein. We interviewed health system managers and/or clinical leaders from all 658 acute care hospitals in Canada and documented key elements of health system infrastructure at the hospital level for these institutions. RESULTS: There was considerable variation across Canada in the availability of key infrastructure for the diagnosis and management of VTE disease. Provinces with higher populations tended to have a large proportion of hospitals with capability to measure d-dimer levels, whereas less populated provinces were more likely to send samples to centralized analysis facilities for d-dimer testing. All provinces and territories had some facilities offering advanced diagnostic imaging, but the number of institutions and the availability of imaging were highly variable (with the proportion offering at least limited availability ranging from 0% to 90%). Only 6 provinces had regions with availability of dedicated early and/or long-term outpatient clinics for VTE disease. CONCLUSIONS: Infrastructure in Canada for optimal care of patients with VTE disease was suboptimal during the study period and was not entirely in step with the evidence. Such shortfalls in health system infrastructure limit the extent to which health care providers can deliver optimal, evidence-based care to their patients. Nationwide evaluations of health system infrastructure such as this one should be undertaken internationally to better characterize quality of care and potential for improvement. Open Medicine Publications, Inc 2014-04-01 /pmc/articles/PMC4085085/ /pubmed/25009684 Text en © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale http://creativecommons.org/licenses/by-sa/2.5/ca/ Open Medicine applies the Creative Commons Attribution Share Alike License, which means that anyone is able to freely copy, download, reprint, reuse, distribute, display or perform this work and that authors retain copyright of their work. Any derivative use of this work must be distributed only under a license identical to this one and must be attributed to the authors. Any of these conditions can be waived with permission from the copyright holder. These conditions do not negate or supersede Fair Use laws in any country. For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/ |
spellingShingle | Research Southern, Danielle A Poole, Jasmine Patel, Alka Waters, Nigel Pilote, Louise Hull, Russell D Ghali, William A Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease |
title | Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease |
title_full | Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease |
title_fullStr | Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease |
title_full_unstemmed | Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease |
title_short | Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease |
title_sort | health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085085/ https://www.ncbi.nlm.nih.gov/pubmed/25009684 |
work_keys_str_mv | AT southerndaniellea healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease AT poolejasmine healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease AT patelalka healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease AT watersnigel healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease AT pilotelouise healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease AT hullrusselld healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease AT ghaliwilliama healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease |